Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

37.30$ -0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 594,941 million DKK. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NVO
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	42,609	314,486	298,921	53,086	397,441	465,795	489,162	482,153	512,288	542,902	559,221	594,941
Current Assets	20,190	139,646	116,421	25,509	195,160	160,897	174,395	162,705	181,883	172,453	177,317	208,696
Cash	4,280	14,392	6,324	7,591	57,018	15,655	38,938	18,435	32,084	26,464	21,127	44,482
Cash & Short-Term Investments	6,758	30,230	9,303	9,004	74,881	26,308	41,550	18,934	32,583	26,962	21,626	44,982
Receivables	7,685	75,261	71,750	9,552	69,497	87,414	86,366	85,843	92,373	75,697	100,268	108,512
Inventory	4,193	31,811	33,600	5,225	37,944	40,849	42,853	45,652	47,504	49,623	51,352	51,352
Property, Plant & Equipment	81,461	–	–	–	119,832	162,488	172,376	180,758	193,244	208,378	–	–
Goodwill	–	4,464	–	–	–	20,064	–	–	–	19,845	19,877	19,890
Intangible Assets	7,912	55,942	59,640	7,976	54,488	91,026	109,379	107,866	106,587	110,208	110,033	102,167
Total Liabilities	29,406	207,925	200,010	36,915	276,919	322,309	350,622	314,087	342,392	348,855	356,156	373,664
Current Liabilities	24,499	169,655	165,606	27,005	208,358	217,528	236,117	207,522	234,358	215,661	225,158	239,083
Short-Term Debt	939	6,478	10,164	784	5,520	13,113	22,413	11,963	12,034	12,017	27,210	18,333
Accounts Payable	2,855	25,606	13,006	4,277	24,079	28,846	19,576	28,206	23,904	19,758	134,053	154,792
Long-Term Debt	19,924	15,976	16,764	51,608	51,452	84,246	96,310	87,305	89,180	118,941	119,172	121,794
Shareholders' Equity	13,203	106,561	98,911	16,171	120,522	143,486	138,540	168,066	169,896	194,047	203,065	221,277
Retained Earnings	13,025	104,839	99,050	16,118	121,670	144,448	137,319	164,453	168,529	195,298	206,420	224,164
Shares Outstanding	4,489	4,477	4,471	4,465	4,461	4,461	4,446	4,447	4,447	4,448	4,449	4,436

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings